WAY-309060

CAS No. 309951-18-6

WAY-309060( —— )

Catalog No. M28814 CAS No. 309951-18-6

WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 39 In Stock
25MG 79 In Stock
50MG 128 In Stock
100MG 210 In Stock
200MG 300 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-309060
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
  • Description
    WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    309951-18-6
  • Formula Weight
    262.26
  • Molecular Formula
    C13H14N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (381.30 mM)
  • SMILES
    Cc1cc(NC(c(cc2)cc(OC)c2OC)=O)no1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.LEXICON PHARMACEUTICALS INC - US2012/65200, 2012, A1
molnova catalog
related products
  • GNE-064

    GNE-064 is a selective, orally active and highly soluble inhibitor of SMARCA4, SMARCA2 and PBRM1 bromodomains 5.

  • BRD4 Inhibitor-20

    BRD4 Inhibitor-20 is a potent bromodomain protein 4 (BRD4) inhibitor with oral activity, demonstrating antiproliferative effects in cancer cell lines and used in studies of various cancers, including colon cancer.

  • BAZ1A-IN-1

    BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.